GENE ONLINE|News &
Opinion
Blog

2025-11-28|

New Nomogram Developed to Predict Severe RSV-Associated ALRTI in Asian Pediatric Populations

by GOAI
Share To

A recent study published in *BMC Pediatrics* introduces a new nomogram designed to predict severe cases of respiratory syncytial virus (RSV)-associated acute lower respiratory tract infections (ALRTI) in children across Asia. The research, led by Tian and colleagues, aims to address the significant global health burden posed by RSV, which is a leading cause of respiratory illness in young children worldwide.

The study highlights the development of this predictive tool specifically tailored for pediatric populations in Asia, where RSV-related illnesses are prevalent. Researchers focused on creating an accessible and accurate method to identify children at higher risk of severe disease. By analyzing clinical data from affected patients, the team developed a model that incorporates various factors contributing to disease severity. This nomogram could potentially aid healthcare providers in early identification and intervention for high-risk cases, though further studies may be needed to validate its effectiveness across broader populations.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 28, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Takeda R&D President Andy Plump and GV Managing Partner Krishna Yeshwant Announce Retirements
2026-09-12
Shine Spect USA Updates Clinical and Safety Guidelines for Xenon Xe-133 Gas
2026-09-11
Amorepacific Updates Hera Black Cushion Ingredient Disclosures for Ten Foundation Shades
2026-09-11
AvKARE Updates Prescribing Information for Etonogestrel and Ethinyl Estradiol Vaginal Ring
2026-09-11
Record Investor Attendance at NLS Days 2026 Drives Nordic Life Science Dealmaking
2026-09-11
Disc Medicine and Silence Therapeutics Develop Polycythemia Vera Treatments to Compete With Takeda and Protagonist
2026-09-11
Leucine Supplementation Linked to Reduced Lymphoid Malignancy Growth and Improved Survival in Study
2026-09-11
Scroll to Top